Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Active, Not Recruiting

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Kaiser Permanente Los Angeles, California, United States
  • Miami Cancer Institute/Baptist Health South Florida Miami, Florida, United States
  • LSU Health Sciences Center New Orleans, Louisiana, United States
  • University of Cincinnati Cancer Institute Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire

NCT03614689

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
  • The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China
  • Sichuan Cancer Hospital Chengdu, Sichuan, China
  • Affiliated Cancer Hospital of Xinjiang Medical University Ürümqi, Xinjiang, China
View Trial Details
Active, Not Recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions
Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations
  • Huai'an First People's Hospital Huai'an, China
  • Nanjing Drum Tower Hospital Nanjing, China
  • Zhongda Hospital Southeast University Nanjing, China
  • The First Affiliated Hospital of Soochow University Suzhou, China
View Trial Details
Active, Not Recruiting

Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer

NCT03732950

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 23 locations
View Trial Details

Related conditions